幹細胞・臍帯血バンクの世界市場レポート 2025年

幹細胞・臍帯血バンクの市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.0％で217億8,000万米ドルに成長します。予測期間の成長は、個別化医療、新興治療、国際展開、バイオテクノロジーへの投資、法的・倫理的枠組みなどに起因すると考えられます。予測期間における主な動向としては、非侵襲的な採取方法、複数のバンキングサービス、透明性と規制、共同作業、保管イノベーションなどが挙げられます。

がん患者の増加は、幹細胞・臍帯血バンク市場の主要な促進要因です。白血病や多発性骨髄腫などのがん疾患は、幹細胞移植によって治療することができます。幹細胞移植の治療には、移植を受ける人と同じ人から幹細胞を採取する自家移植と、適合した血縁者または血縁関係のないドナーから幹細胞を採取する同種移植があります。がんの治療に幹細胞を使うことで、化学療法で傷ついた血液を作る幹細胞を回復させることができます。例えば、米国を拠点とする非営利のがん擁護団体である米国がん協会によると、2023年1月のがん患者数は195万8,310人となり、2021年の189万8,160人から3.16％増加しました。このように、がん患者数の増加が幹細胞/臍帯血バンク市場の成長を牽引しています。

慢性疾患の増加は、今後数年間の幹細胞・臍帯血バンク市場の拡大を牽引すると予想されます。慢性疾患とは、3ヵ月以上続く長期的な病気で、時間の経過とともに悪化する可能性があります。多くの慢性疾患に対する効果的な治療法は限られているため、幹細胞や臍帯血の再生可能性が治療応用のためにますます研究されています。幹細胞移植、個別化医療、慢性疾患の新たな治療法に関する臨床研究はすべて増加傾向にあり、バンキングサービスに対する需要の高まりにつながっています。例えば、スイスに本部を置く世界保健機関（WHO）は2024年2月、2050年までに新たに発生するがん患者は3,500万人を超え、2022年の推定2,000万人から77％増加すると予測しました。その結果、慢性疾患の増加が幹細胞・臍帯血バンキング市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の幹細胞・臍帯血バンク市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の幹細胞・臍帯血バンク市場：成長率分析
• 世界の幹細胞・臍帯血バンク市場の実績：規模と成長、2019～2024年
• 世界の幹細胞・臍帯血バンク市場の予測：規模と成長、2024～2029年、2034年
• 世界の幹細胞・臍帯血バンク総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の幹細胞・臍帯血バンク市場：細胞タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 成体幹細胞
• 臍帯血幹細胞
• 胚性幹細胞
• 世界の幹細胞・臍帯血バンク市場：サービス別、実績と予測、2019～2024年、2024～2029年、2034年
• 収集
• 処理
• 分析
• 保管
• 世界の幹細胞・臍帯血バンク市場：バンクタイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 公共
• 民間
• 世界の幹細胞・臍帯血バンク市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 白血病
• 貧血
• サラセミア
• 自閉症
• 脳性麻痺
• 糖尿病
• その他
• 世界の幹細胞・臍帯血バンク市場：成体幹細胞のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 造血幹細胞（HSC）
• 間葉系幹細胞（MSC）
• 神経幹細胞（NSC）
• 人工多能性幹細胞（iPSC）
• 世界の幹細胞・臍帯血バンク市場：臍帯血幹細胞のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 臍帯血由来の造血幹細胞（HSC）
• 臍帯血由来の間葉系幹細胞（MSC）
• 世界の幹細胞・臍帯血バンク市場：胚性幹細胞のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ヒト胚由来の胚性幹細胞（ESC）
• ヒト胚性生殖細胞由来の幹細胞

第7章 地域別・国別分析

• 世界の幹細胞・臍帯血バンク市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の幹細胞・臍帯血バンク市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 幹細胞・臍帯血バンク市場：競合情勢
• 幹細胞・臍帯血バンク市場：企業プロファイル
  • AMAG Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Cryo-Cell International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Esperite NV Overview, Products and Services, Strategy and Financial Analysis
  • Americord Registry LLC Overview, Products and Services, Strategy and Financial Analysis
  • China Cord Blood Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Cordlife Group Ltd.
• CordVida
• Cryo Stemcell
• PerkinElmer Inc.
• ReeLabs Pvt Ltd.
• Smart Cells International Ltd.
• Stemade Biotech Pvt Ltd.
• ViaCord Inc.
• Americord Registry LLC
• LifeCell International
• Cryoviva Biotech Pvt Ltd.
• Cytori Therapeutics Inc.
• Thermo Fisher Scientific Inc.
• Cord Blood America Inc.
• StemCyte Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 幹細胞・臍帯血バンク市場2029：新たな機会を提供する国
• 幹細胞・臍帯血バンク市場2029：新たな機会を提供するセグメント
• 幹細胞・臍帯血バンク市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Stem cell or cord blood banking is the practice of storing stem cells or blood obtained from the umbilical cord, with the aim of using them in the future for medical treatment. By extracting stem cells from the placenta and umbilical cord and preserving them, cord blood banking holds the potential to save lives through regenerative medicine.

The primary cell types involved in stem cell and cord blood banking are adult stem cells, umbilical cord blood stem cells, and embryonic stem cells. Adult stem cells are a relatively rare group of cells found in the body during most of postnatal life. They have the capacity to generate a limited number of mature cell types specific to the tissue in which they are located. The various services provided in this field encompass collection, processing, analysis, and storage. These services are offered by different types of banks, including private banks and public banks. The applications for stem cell and cord blood banking are diverse and include conditions such as leukemia, anemia, thalassemia, autism, cerebral palsy, diabetes, and many others.

The stem cell/cord blood banking market research report is one of a series of new reports from The Business Research Company that provides stem cell/cord blood banking market statistics, including stem cell/cord blood banking industry global market size, regional shares, competitors with a stem cell/cord blood banking market share, detailed stem cell/cord blood banking market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell/cord blood banking industry. This stem cell/cord blood banking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell/cord blood banking market size has grown strongly in recent years. It will grow from $12.26 billion in 2024 to $13.36 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to medical advancements, increased awareness, successful clinical applications, regulatory support, research funding.

The stem cell/cord blood banking market size is expected to see rapid growth in the next few years. It will grow to $21.78 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to personalized medicine, emerging therapies, international expansion, investment in biotechnology, legal and ethical framework. Major trends in the forecast period include non-invasive collection methods, multiple banking services, transparency and regulation, collaborative efforts, storage innovations.

Increasing number of cancer patients is a major driver for the stem cell /cord blood banking market. Cancer diseases such as leukemia and multiple myeloma can be treated by stem cell transplant. In stem cell transplant, treatment can be either done by autologous transplant in which the stem cells come from the same person who gets the transplant or by allogeneic transplant in which means the stem cells come from a matched related or unrelated donor. By using stem cells in the treatment of cancer, the blood forming stem cells which are damaged during chemotherapy can be restored. For instance, in January 2023, according to the American Cancer Society, a US-based non-profit cancer advocacy organization, the number of cancer cases increased to 1,958,310 in 2023, reflecting a growth of 3.16% from 1,898,160 in 2021. Thus, increasing number of cancer patients is driving the growth of the stem cell /cord blood banking market.

The growing prevalence of chronic diseases is expected to drive the expansion of the stem cell/cord blood banking market in the coming years. Chronic diseases are long-term illnesses that persist for three months or more and may worsen over time. Since effective treatments for many chronic conditions are limited, the regenerative potential of stem cells and cord blood is being increasingly explored for therapeutic applications. Stem cell transplants, personalized medicine, and clinical research into new treatments for chronic conditions are all on the rise, leading to higher demand for banking services. For example, in February 2024, the World Health Organization, based in Switzerland, projected that by 2050, there would be over 35 million new cancer cases, a 77% increase from the estimated 20 million cases in 2022. As a result, the growing prevalence of chronic diseases is fueling the growth of the stem cell and cord blood banking market.

An emerging trend in the stem cell/cord blood banking market is the pairing of cord blood and tissue storage with genetic testing services. This pairing offers complimentary services to existing clients, expanding their product portfolios. For instance, genetic testing company Natera introduced the Evercord cord blood and tissue storage service, enabling expectant parents to collect, store, and potentially retrieve their newborn's cord blood and tissue for therapeutic use in transplantation and regenerative medicine applications.

Major companies operating in the stem cell/cord blood banking market are developing peripheral blood stem cell processing and storage services to gain a competitive advantage. This involves the collection, processing, testing, and cryopreservation of hematopoietic stem cells (HSCs) obtained from a patient's peripheral blood. Cordlife Group Limited, a Singapore-based healthcare company, launched a new peripheral blood stem cell (PBSC) processing and storage service in Singapore in February 2023. This service supports patients requiring hematopoietic stem cell transplantation for various blood-related diseases, including leukemia, myeloma, and lymphoma. Cordlife collaborates with the Centre for Clinical Hematology (CFCH) to offer eligible patients stem cell mobilization and harvesting, with Cordlife handling the subsequent processing, testing, and cryopreservation of PBSCs. This new service aims to improve treatment outcomes for individuals requiring hematopoietic stem cell transplants in Singapore.

In July 2024, Cytomed Therapeutics, a Singapore-based biopharmaceutical company, acquired Cellsafe International Sdn Bhd for US $490,000. This acquisition is aimed at reinforcing its strategy to develop allogeneic, off-the-shelf donor-derived gamma delta (Yδ) T cell therapies for the treatment of solid and liquid cancers. Cellsafe International Sdn Bhd is a Malaysia-based cord blood bank company.

Major companies operating in the stem cell/cord blood banking market include AMAG Pharmaceuticals Inc., Cryo-Cell International Inc., Esperite NV, Americord Registry LLC, China Cord Blood Corporation, Cordlife Group Ltd., CordVida, Cryo Stemcell, PerkinElmer Inc., ReeLabs Pvt Ltd., Smart Cells International Ltd., Stemade Biotech Pvt Ltd., ViaCord Inc., Americord Registry LLC, LifeCell International, Cryoviva Biotech Pvt Ltd., Cytori Therapeutics Inc., Thermo Fisher Scientific Inc., Cord Blood America Inc., StemCyte Inc., Brainstorm Cell Therapeutics Inc., Cord Blood Registry Systems Inc., Healthbanks Biotech Usa Inc., Cryo-save Private Ltd., New York Cord Blood Center, CryoHoldco, Vita 34 International AG, Reliance Life Sciences Pvt Ltd., Maze Cord Blood Laboratories, Cells4Life Group LLP

North America was the largest region in the stem cell/cord blood banking market in 2024. Western Europe was the second largest region in the stem cell/cord blood banking market analysis. The regions covered in the stem cell/cord blood banking market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the stem cell/cord blood banking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The stem cell/cord blood banking global market includes revenues earned by entities by providing services such as cryopreservation and collection services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell/Cord Blood Banking Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell/cord blood banking market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell/cord blood banking ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stem cell/cord blood banking market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Cell Type: Adult Stem Cells; Umbilical Cord Blood Stem Cells; Embryonic Stem Cells
• 2) By Service: Collection; Processing; Analysis; Storage
• 3) By Bank Type: Public; Private
• 4) By Application: Leukemia; Anemia; Thalassemia; Autism; Cerebral Palsy; Diabetes; Other Applications
• Subsegments:
• 1) By Adult Stem Cells: Hematopoietic Stem Cells (HSC); Mesenchymal Stem Cells (MSC); Neural Stem Cells (NSC); Induced Pluripotent Stem Cells (iPSCs)
• 2) By Umbilical Cord Blood Stem Cells: Hematopoietic Stem Cells (HSC) From Cord Blood; Mesenchymal Stem Cells (MSC) From Cord Blood
• 3) By Embryonic Stem Cells: Embryonic Stem Cells (ESCs) From Human Embryos; Stem Cells Derived From Human Embryonic Germ Cells
• Companies Mentioned: AMAG Pharmaceuticals Inc.; Cryo-Cell International Inc.; Esperite NV; Americord Registry LLC; China Cord Blood Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stem Cell/Cord Blood Banking Market Characteristics

3. Stem Cell/Cord Blood Banking Market Trends And Strategies

4. Stem Cell/Cord Blood Banking Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Stem Cell/Cord Blood Banking Growth Analysis And Strategic Analysis Framework

• 5.1. Global Stem Cell/Cord Blood Banking PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Stem Cell/Cord Blood Banking Market Growth Rate Analysis
• 5.4. Global Stem Cell/Cord Blood Banking Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Stem Cell/Cord Blood Banking Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Stem Cell/Cord Blood Banking Total Addressable Market (TAM)

6. Stem Cell/Cord Blood Banking Market Segmentation

• 6.1. Global Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult Stem Cells
• Umbilical Cord Blood Stem Cells
• Embryonic Stem Cells
• 6.2. Global Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Collection
• Processing
• Analysis
• Storage
• 6.3. Global Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Public
• Private
• 6.4. Global Stem Cell/Cord Blood Banking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukemia
• Anemia
• Thalassemia
• Autism
• Cerebral Palsy
• Diabetes
• Other Applications
• 6.5. Global Stem Cell/Cord Blood Banking Market, Sub-Segmentation Of Adult Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hematopoietic Stem Cells (HSC)
• Mesenchymal Stem Cells (MSC)
• Neural Stem Cells (NSC)
• Induced Pluripotent Stem Cells (iPSCs)
• 6.6. Global Stem Cell/Cord Blood Banking Market, Sub-Segmentation Of Umbilical Cord Blood Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hematopoietic Stem Cells (HSC) From Cord Blood
• Mesenchymal Stem Cells (MSC) From Cord Blood
• 6.7. Global Stem Cell/Cord Blood Banking Market, Sub-Segmentation Of Embryonic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Embryonic Stem Cells (ESCs) From Human Embryos
• Stem Cells Derived From Human Embryonic Germ Cells

7. Stem Cell/Cord Blood Banking Market Regional And Country Analysis

• 7.1. Global Stem Cell/Cord Blood Banking Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Stem Cell/Cord Blood Banking Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stem Cell/Cord Blood Banking Market

• 8.1. Asia-Pacific Stem Cell/Cord Blood Banking Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stem Cell/Cord Blood Banking Market

• 9.1. China Stem Cell/Cord Blood Banking Market Overview
• 9.2. China Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stem Cell/Cord Blood Banking Market

• 10.1. India Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stem Cell/Cord Blood Banking Market

• 11.1. Japan Stem Cell/Cord Blood Banking Market Overview
• 11.2. Japan Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stem Cell/Cord Blood Banking Market

• 12.1. Australia Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stem Cell/Cord Blood Banking Market

• 13.1. Indonesia Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stem Cell/Cord Blood Banking Market

• 14.1. South Korea Stem Cell/Cord Blood Banking Market Overview
• 14.2. South Korea Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stem Cell/Cord Blood Banking Market

• 15.1. Western Europe Stem Cell/Cord Blood Banking Market Overview
• 15.2. Western Europe Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stem Cell/Cord Blood Banking Market

• 16.1. UK Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stem Cell/Cord Blood Banking Market

• 17.1. Germany Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stem Cell/Cord Blood Banking Market

• 18.1. France Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stem Cell/Cord Blood Banking Market

• 19.1. Italy Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stem Cell/Cord Blood Banking Market

• 20.1. Spain Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stem Cell/Cord Blood Banking Market

• 21.1. Eastern Europe Stem Cell/Cord Blood Banking Market Overview
• 21.2. Eastern Europe Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stem Cell/Cord Blood Banking Market

• 22.1. Russia Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stem Cell/Cord Blood Banking Market

• 23.1. North America Stem Cell/Cord Blood Banking Market Overview
• 23.2. North America Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stem Cell/Cord Blood Banking Market

• 24.1. USA Stem Cell/Cord Blood Banking Market Overview
• 24.2. USA Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stem Cell/Cord Blood Banking Market

• 25.1. Canada Stem Cell/Cord Blood Banking Market Overview
• 25.2. Canada Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stem Cell/Cord Blood Banking Market

• 26.1. South America Stem Cell/Cord Blood Banking Market Overview
• 26.2. South America Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stem Cell/Cord Blood Banking Market

• 27.1. Brazil Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stem Cell/Cord Blood Banking Market

• 28.1. Middle East Stem Cell/Cord Blood Banking Market Overview
• 28.2. Middle East Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stem Cell/Cord Blood Banking Market

• 29.1. Africa Stem Cell/Cord Blood Banking Market Overview
• 29.2. Africa Stem Cell/Cord Blood Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Stem Cell/Cord Blood Banking Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Stem Cell/Cord Blood Banking Market, Segmentation By Bank Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stem Cell/Cord Blood Banking Market Competitive Landscape And Company Profiles

• 30.1. Stem Cell/Cord Blood Banking Market Competitive Landscape
• 30.2. Stem Cell/Cord Blood Banking Market Company Profiles
  • 30.2.1. AMAG Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cryo-Cell International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Esperite NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Americord Registry LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. China Cord Blood Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Stem Cell/Cord Blood Banking Market Other Major And Innovative Companies

• 31.1. Cordlife Group Ltd.
• 31.2. CordVida
• 31.3. Cryo Stemcell
• 31.4. PerkinElmer Inc.
• 31.5. ReeLabs Pvt Ltd.
• 31.6. Smart Cells International Ltd.
• 31.7. Stemade Biotech Pvt Ltd.
• 31.8. ViaCord Inc.
• 31.9. Americord Registry LLC
• 31.10. LifeCell International
• 31.11. Cryoviva Biotech Pvt Ltd.
• 31.12. Cytori Therapeutics Inc.
• 31.13. Thermo Fisher Scientific Inc.
• 31.14. Cord Blood America Inc.
• 31.15. StemCyte Inc.

32. Global Stem Cell/Cord Blood Banking Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stem Cell/Cord Blood Banking Market

34. Recent Developments In The Stem Cell/Cord Blood Banking Market

35. Stem Cell/Cord Blood Banking Market High Potential Countries, Segments and Strategies

• 35.1 Stem Cell/Cord Blood Banking Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Stem Cell/Cord Blood Banking Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Stem Cell/Cord Blood Banking Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer